Product
HPC,A
1 clinical trial
7 indications
Indication
Acute Lymphoblastic LeukemiaIndication
Acute Myeloid LeukemiaIndication
Myeloid SarcomaIndication
Chronic Myeloid LeukemiaIndication
Juvenile Myelomonocytic LeukemiaIndication
Myelodysplastic SyndromeIndication
Non-Hodgkin LymphomaClinical trial
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior TransplantationStatus: Recruiting, Estimated PCD: 2024-07-01